跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLP-1 agonist (oral, obesity/diabetes)
首页
药物
GLP-1 agonist (oral, obesity/diabetes)
GLP-1 agonist (oral, obesity/diabetes)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS OF TREATING A DISEASE OR CONDITION ASSOCIATED WITH WEIGHT GAIN
申请人: BIOAGE LABS INC
优先权: 2024
WO
COMPOSITIONS COMPRISING LUTEOLIN AND/OR LUTEOLIN-7-O-Β-D-GLUCOSIDE, METHODS OF MAKING AND USING THE SAME
申请人: ACCESS BUSINESS GROUP INT LLC
优先权: 2024
CN
WO
2 件公开
SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP 1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST
申请人: BAHEKAR RAJESH
优先权: 2009
US
COMBINATION OF BITTER RECEPTOR AGONIST AND GUT-SIGNALING COMPOUND
申请人: AARDVARK THERAPEUTICS INC
优先权: 2022
US
Combination of bitter receptor agonists and intestinal signaling compounds
申请人: ADAVAC THERAPEUTICS INC
优先权: 2022
CN
药物
反馈
